198 related articles for article (PubMed ID: 23298905)
1. Cadherin-17 induces tumorigenesis and lymphatic metastasis in gastric cancer through activation of NFκB signaling pathway.
Wang J; Kang WM; Yu JC; Liu YQ; Meng QB; Cao ZJ
Cancer Biol Ther; 2013 Mar; 14(3):262-70. PubMed ID: 23298905
[TBL] [Abstract][Full Text] [Related]
2. Targeting cadherin-17 inactivates Ras/Raf/MEK/ERK signaling and inhibits cell proliferation in gastric cancer.
Lin Z; Zhang C; Zhang M; Xu D; Fang Y; Zhou Z; Chen X; Qin N; Zhang X
PLoS One; 2014; 9(1):e85296. PubMed ID: 24465527
[TBL] [Abstract][Full Text] [Related]
3. CDH17 alters MMP-2 expression via canonical NF-κB signalling in human gastric cancer.
Jiang XJ; Lin J; Cai QH; Zhao JF; Zhang HJ
Gene; 2019 Jan; 682():92-100. PubMed ID: 29783070
[TBL] [Abstract][Full Text] [Related]
4. Knockdown of liver-intestine cadherin decreases BGC823 cell invasiveness and metastasis in vivo.
Xu Y; Zhang J; Liu QS; Dong WG
World J Gastroenterol; 2012 Jun; 18(24):3129-37. PubMed ID: 22791949
[TBL] [Abstract][Full Text] [Related]
5. Targeting CDH17 suppresses tumor progression in gastric cancer by downregulating Wnt/β-catenin signaling.
Qiu HB; Zhang LY; Ren C; Zeng ZL; Wu WJ; Luo HY; Zhou ZW; Xu RH
PLoS One; 2013; 8(3):e56959. PubMed ID: 23554857
[TBL] [Abstract][Full Text] [Related]
6. Inhibition of CDH17 gene expression via RNA interference reduces proliferation and apoptosis of human MKN28 gastric cancer cells.
Li R; Yang HQ; Xi HL; Feng S; Qin RH
Int J Oncol; 2017 Jan; 50(1):15-22. PubMed ID: 27909714
[TBL] [Abstract][Full Text] [Related]
7. Lentiviral-mediated miRNA against liver-intestine cadherin suppresses tumor growth and invasiveness of human gastric cancer.
Liu QS; Zhang J; Liu M; Dong WG
Cancer Sci; 2010 Aug; 101(8):1807-12. PubMed ID: 20500517
[TBL] [Abstract][Full Text] [Related]
8. The predictive effect of cadherin-17 on lymph node micrometastasis in pN0 gastric cancer.
Wang J; Yu JC; Kang WM; Wang WZ; Liu YQ; Gu P
Ann Surg Oncol; 2012 May; 19(5):1529-34. PubMed ID: 22009269
[TBL] [Abstract][Full Text] [Related]
9. Correlation of cadherin-17 protein expression with clinicopathological features and prognosis of patients with sporadic gastric cancer.
Meng W; Gu T; Gao LM; Zong ZG; Meng L; Fu ZZ; Guo L
Braz J Med Biol Res; 2015 Dec; 48(12):1077-86. PubMed ID: 26421870
[TBL] [Abstract][Full Text] [Related]
10.
Fujiwara K; Tsuji AB; Sudo H; Sugyo A; Akiba H; Iwanari H; Kusano-Arai O; Tsumoto K; Momose T; Hamakubo T; Higashi T
Ann Nucl Med; 2020 Jan; 34(1):13-23. PubMed ID: 31605356
[TBL] [Abstract][Full Text] [Related]
11. OxLDL promotes lymphangiogenesis and lymphatic metastasis in gastric cancer by upregulating VEGF‑C expression and secretion.
Ma C; Xie J; Luo C; Yin H; Li R; Wang X; Xiong W; Zhang T; Jiang P; Qi W; Zhou T; Yang Z; Wang W; Ma J; Gao G; Yang X
Int J Oncol; 2019 Feb; 54(2):572-584. PubMed ID: 30483757
[TBL] [Abstract][Full Text] [Related]
12. YAP1 enhances cell proliferation, migration, and invasion of gastric cancer in vitro and in vivo.
Sun D; Li X; He Y; Li W; Wang Y; Wang H; Jiang S; Xin Y
Oncotarget; 2016 Dec; 7(49):81062-81076. PubMed ID: 27835600
[TBL] [Abstract][Full Text] [Related]
13. Coupling CDH17 and CLDN18 markers for comprehensive membrane-targeted detection of human gastric cancer.
Matsusaka K; Ushiku T; Urabe M; Fukuyo M; Abe H; Ishikawa S; Seto Y; Aburatani H; Hamakubo T; Kaneda A; Fukayama M
Oncotarget; 2016 Sep; 7(39):64168-64181. PubMed ID: 27580354
[TBL] [Abstract][Full Text] [Related]
14. Blockade of proliferation and migration of gastric cancer via targeting CDH17 with an artificial microRNA.
Zhang J; Liu QS; Dong WG
Med Oncol; 2011 Jun; 28(2):494-501. PubMed ID: 20393816
[TBL] [Abstract][Full Text] [Related]
15. MicroRNA-1275 inhibits cell migration and invasion in gastric cancer by regulating vimentin and E-cadherin via JAZF1.
Mei JW; Yang ZY; Xiang HG; Bao R; Ye YY; Ren T; Wang XF; Shu YJ
BMC Cancer; 2019 Jul; 19(1):740. PubMed ID: 31357957
[TBL] [Abstract][Full Text] [Related]
16. Upregulation of miRNA‑301a‑3p promotes tumor progression in gastric cancer by suppressing NKRF and activating NF‑κB signaling.
Xu X; Xia Y; Ma J; Li W; Niu N; Li X; Tao H; Xu J; He X
Int J Oncol; 2020 Aug; 57(2):522-532. PubMed ID: 32468020
[TBL] [Abstract][Full Text] [Related]
17. CDH17 is a downstream effector of HOXA13 in modulating the Wnt/β-catenin signaling pathway in gastric cancer.
Qu LP; Zhong YM; Zheng Z; Zhao RX
Eur Rev Med Pharmacol Sci; 2017 Mar; 21(6):1234-1241. PubMed ID: 28387908
[TBL] [Abstract][Full Text] [Related]
18. AEG-1 induces gastric cancer metastasis by upregulation of eIF4E expression.
Wu S; Yang L; Wu D; Gao Z; Li P; Huang W; Wang X
J Cell Mol Med; 2017 Dec; 21(12):3481-3493. PubMed ID: 28661037
[TBL] [Abstract][Full Text] [Related]
19. An RGD motif present in cadherin 17 induces integrin activation and tumor growth.
Bartolomé RA; Peláez-García A; Gomez I; Torres S; Fernandez-Aceñero MJ; Escudero-Paniagua B; Imbaud JI; Casal JI
J Biol Chem; 2014 Dec; 289(50):34801-14. PubMed ID: 25336636
[TBL] [Abstract][Full Text] [Related]
20. microRNA-203 suppresses invasion of gastric cancer cells by targeting ERK1/2/Slug/ E-cadherin signaling.
Gao P; Wang S; Jing F; Zhan J; Wang Y
Cancer Biomark; 2017; 19(1):11-20. PubMed ID: 28269747
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
